학술논문
CNTO6785, a fully human antIInterleukin 17 monoclonal antibody, in patients with rheumatoid arthritis with inadequate response to methotrexate: A randomized, placebo-controlled, phase II, dose-ranging study
Document Type
Article
Author
Source
In: Journal of Rheumatology . (Journal of Rheumatology, 1 January 2018, 45(1):22-31)
Subject
Language
English
ISSN
14992752
0315162X
0315162X